![Günther Loidl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Günther Loidl
Chief Tech/Sci/R&D Officer at
BACHEM HOLDING AG
Net worth: 2 M $ as of 2026-05-30
Profile
Dr. Günther Loidl is a Chief Technology Officer at Bachem Holding AG. He is on the Board of Directors at Bachem AG. He received his doctorate degree from Max Planck Institute of Biochemistry.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-30 | 17,500 ( 0.02% ) | 2 M $ | 2026-05-30 |
Günther Loidl active positions
| Companies | Position | Start |
|---|---|---|
| BACHEM HOLDING AG | Chief Tech/Sci/R&D Officer | 2014-12-31 |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Director/Board Member | 1999-12-31 |
Training of Günther Loidl
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Bachem Holding AG
 Bachem Holding AG Pharmaceuticals: MajorHealth Technology Operates as an independent, technology-based, public biochemical company | Health Technology |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Health Technology |
Max Planck Institute of Biochemistry
 Max Planck Institute of Biochemistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Günther Loidl
Choose MarketScreener 
